Steve E. Rubi. Pediatric ophthalmology and strabismus. Mosby, 1995, 140(2): 724-724. DOI : 10.1016/j.ajo.2005.06.039 .
[4]
Laojaroenwanit S, Layanun V, Praneeprachachon P, et al. Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises. Clin Ophthalmol, 2016, 10: 897- 902. DOI: 10.2147/OPTH.S102611.
[5]
Yazdani N, Sadeghi R, Momeni-Moghaddam H, et al. Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis. J Optom, 2018, 11(3):
Rizzi RR, Ho J. Post resuscitation central anticholinergic syndrome. Resuscitation, 2004, 61(1): 101-102. DOI: 10.1016/j. resuscitation.2003.12.023.
[9]
Nagesh HN. Acute psychosis induced by topical cyclopentolate eye drops in a young child. J Pharm Sci, 2017, 6(6): 1512-1516. DOI: 10.20959/wjpps20176-9382.
[10]
Wuthrich B, Bigler Anit M, Kuhn M, et al. Systemic anticholinergicside-effects. Allergy, 2000, 55(8): 788-789. DOI: 10.1034/j.1398-9995.2000.00733.x.
[11]
Patel AJ, Simon JW, Hodgetts DJ. Cycloplegic and mydriatic agents for routine ophthalmologic examination: a survey of pediatric ophthalmologists. J AAPOS, 2004, 8(3): 274-277.
DOI: 10.1016/S1091853104000084.
[12]
Lahdes K, Huupponen R, Kaila T, et al. Systemic absorption of ocular cyclopentolate in children. Ger J Ophthalmol, 1992, 1(1): 16-18.